早期双相障碍辅助心理治疗:随机对照试验研究方案
本研究为多中心随机对照试验,计划纳入300例双相障碍患者,随机分配至特异性情绪认知治疗(SECT)组或情绪聚焦支持治疗(EFST)主动对照组,每组接受为期4个月、每月一次、共48小时的小组心理治疗。主要随访点为18个月,评估复发率、整体适应功能及神经心理功能。
要点
- 早期双相障碍辅助小组心理治疗的多中心RCT研究方案
- SECT与EFST主动对照比较,每组48小时治疗,随访至18个月
- 主要结局为复发率、整体功能及神经心理功能
核心结论
- 该研究旨在检验特异性小组心理治疗相对于主动对照在复发率、整体功能和神经心理功能方面的效果。
研究设计与样本
- 多中心随机对照试验,计划纳入300例双相障碍患者,随机分配至SECT组或EFST主动对照组。
- 每组接受共48小时小组治疗,每月一次,持续4个月。
- 评估时间点为基线(t1)、6个月随访(t2)、12个月随访(t3)和18个月随访(t4),18个月为主要时间点。
关键数值与推荐
- 每组治疗总量为48小时,每月一次,持续4个月。
- 主要随访时间点为18个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bipolar disorders are serious illnesses with a chronic course and a high rate of relapse. Typically, bipolar disorders onset during adolescence or early adulthood, with patients experiencing significant personal and social costs as a consequence of their illness. Despite this, to date, there is limited (controlled) evidence regarding the effectiveness of psychotherapy during the critical stages of the disorder (e.g., early onset). Some preliminary studies suggest that targeted, tailored early interventions in particular may improve disease prognosis. The proposed study examines the effectiveness of group psychotherapy on relapse prevention, global adaptive functioning, and neuropsychological functioning in early-stage bipolar disorder. METHODS: In this multicenter randomized controlled trial (RCT), 300 patients with bipolar disorder are randomized to one of two group psychotherapies: Specific Emotional-Cognitive Therapy (SECT; intervention group) or Emotion-Focused Supportive Therapy (EFST; active control group). Each therapy comprises of a total of 48-h sessions (delivered once a month) over a period of 4 months. Assessments take place at baseline (t1); 6 months follow-up, i.e., post-intervention (t2); 12 months follow-up (t3); and 18 months follow-up (t4), whereby 18 months follow-up is the primary time point of interest. DISCUSSION: The goal of this study is to test the effects of an innovative, specific group therapy relative to an active control condition in terms of rates of relapse, global functioning, and neuropsychological functioning. Pending the outcomes of the trial, it will be possible to establish a firm evidence base for accessible group psychotherapy adjuvant to routine psychiatric care for individuals with bipolar disorder. TRIAL REGISTRATION: USA: ClinicalTrials.gov NCT02506322 . Registered on 19 December 2014; Germany: German Clinical Trials Register DRKS00006013 . Registered on21 May 2015.
引用
- Stamm TJ, Zwick JC, O'Malley G, et al. Adjuvant psychotherapy in early-stage bipolar disorder: study protocol for a randomized controlled trial. Trials. 2020. PMID: 33050952. doi:10.1186/s13063-020-04755-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。